Parkinson’s Progress: Insights on Advanced Therapies
Per Odin, professor at Lund University in Sweden, discusses advanced therapies for Parkinson’s disease. These therapies have been available for nearly 30 years, with various products introduced over time. Notably, new treatments, such as subcutaneus L-dopa, is expected to enter the market soon. These new treatments could significantly improve the quality of life for patients with advanced Parkinson’s disease while displaying favorable cost-benefits. Let Per Odin elaborate in this MEDtalk.
Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.